Contact Us
Important Notice Regarding Email Communications
Please do not include any personally identifiable information, protected health information (“PHI”), or other sensitive or confidential information in any email message to the Medical Information email address listed below.
The Medical Information email address is intended for general, non-confidential inquiries only. Email communications may not be secure and could be subject to unauthorized access during transmission.
Please do not include any personally identifiable information, protected health information (“PHI”), or other sensitive or confidential information in your message.
If you need to communicate information that includes patient-specific or other sensitive details, please contact us at the relevant phone number below.
Milestone disclaims responsibility for any unauthorized access to or use of information transmitted via this channel.
HEALTHCARE PROFESSIONALS:
For medical inquiries regarding CARDAMYST™ (etripamil) nasal spray or to request additional medical information, please call 1-877-207-4764, Option #1, or send your request to medicalinformation@milestonepharma.com
For grant submissions, such as medical education grants, investigator-initiated studies, and/or patient advocacy grants, please send your request to grants@milestonepharma.com
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
PATIENTS:
If you have a medical emergency, please call 911. If you are experiencing symptoms of PSVT, please call your healthcare provider or call 911. For questions regarding Milestone or CARDAMYST™ (etripamil) nasal spray, please call 1-877-207-4764, Option #2, or send your request to medicalinformation@milestonepharma.com
CARDAMYST™ will be available for patients with PSVT starting early 2026. Talk to your healthcare provider about potential treatment options.
INVESTORS, MEDIA & GENERAL INQUIRIES:
For questions regarding Milestone or etripamil, please send your request to ir@milestonepharma.com
For the latest media updates on Milestone Pharmaceuticals, please send your request to media@milestonepharma.com
For general inquiries regarding Milestone or etripamil, please send your request to info@milestonepharma.com
COMPLIANCE HOTLINE:
To report a violation of company policies, ethical concerns, HR, or legal compliance issues, please call 1-877-207-4764, Option #3. All reports will be handled confidentially and in accordance with company policy. Thank you for helping us maintain the highest standards of integrity.
OFFICE LOCATIONS
Headquarters
Milestone Pharmaceuticals inc.
1111 Dr.-Frederik-Philips Blvd., Ste. 420
Montreal, (Quebec)
H4M 2X6 Canada
Telephone: 1-877-207-4764
Email: info@milestonepharma.com
United States
Milestone Pharmaceuticals USA, Inc.
6210 Ardrey Kell Road, Suite 650
Charlotte, NC 28277
Telephone: 1-877-207-4764
